Diagnamed Holdings Corp. (DMED.CN) Research

Diagnamed Holdings Corp. specializes in developing a software-driven platform that provides prescription digital therapeutic solutions. These solutions are engineered to identify brain age and tremors, critical indicators in the context of neurological disorders. The company's operations are centered in Vancouver, Canada.

Market snapshot

Symbol
DMED.CN
Price
$0.05
Day change
+11.11%
Market cap
$4.6M
P/E ratio
-4.90x
52-week range
0.03-0.25
Sector
Healthcare
Industry
Medical - Healthcare Information Services

Peer companies

  • AI/ML Innovations Inc. (AIML.CN)
  • Avant Brands Inc. (AVNT.TO)
  • Ayurcann Holdings Corp. (AYUR.CN)
  • BioVaxys Technology Corp. (BIOV.CN)
  • CLS Holdings USA, Inc. (CLSH.CN)
  • Crescita Therapeutics Inc. (CTX.TO)
  • Glow Lifetech Corp. (GLOW.CN)
  • Mydecine Innovations Group Inc. (MYCO.NE)

Open Diagnamed Holdings Corp. (DMED.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.